Available Technologies
# of Displayed Technologies: 5 / 5
Generation of T cell-specific CXCR3 Transgenic mouse
TS-062320 — The Need: Addressing Susceptibility to Cutaneous Leishmaniasis
Cutaneous leishmaniasis, caused by the intracellular parasite Leishmania major and transmitted by sand flies, poses a significant threat to susceptible populations. This disfiguring disease results in large skin lesions, impacting both …
- College: College of Arts & Sciences
- Inventors: Satoskar, Abhay; Oghumu, Steve
- Licensing Officer: Dahlman, Jason "Jay"
AR-12 for the Treatment of Leishmaniasis (Protozoa)
TS-041764 — AR-12 is a FDA-IND approved small molecule that has been repurposed to treat leishmaniasis, a parasitic infection.
Leishmaniasis is a protozoal parasitic disease transmitted by sandflies. The disease affects millions of people worldwide. Sandflies carrying the promastigote form of the parasite bite a human host, attracting macrophages to the site of the wound. Promastigotes are then phagocytized by the macroph…
- College: College of Medicine (COM)
- Inventors: Satoskar, Abhay; Ainslie, Kristy; Bachelder, Eric; Gautam, Shalini; Peine, Kevin
- Licensing Officer: Willson, Christopher
CXCR3-GFP knock-in mouse
TS-038221 — A knock-in murine model that expresses high levels of GFP in CXCR3 positive cells.
Chemokines are typically small, secreted molecules that participate in leukocyte trafficking, recruitment, and activation. They also play roles in normal and pathological processes including allergic responses, infectious and autoimmune disease, angiogenesis, inflammation, and tumor growth and met…
- College: College of Arts & Sciences
- Inventors: Satoskar, Abhay; Oghumu, Steve
- Licensing Officer: Dahlman, Jason "Jay"
Novel Immunomodulators and Vaccine Adjuvants
TS-038032 — A class of compounds possessing potent immunomodulatory activity, to enhance the protection of vaccines against infectious agents.
While vaccines are commonly used today for a variety of diseases and have proven efficacious for disease prevention, some vaccines do not efficiently activate an immune response. About 10% of vaccinations fail to mount adequate antibody levels to routine vaccinations. Also, many viruses rapidly mu…
- College: College of Medicine (COM)
- Inventors: Satoskar, Abhay; Ainslie, Kristy; Bachelder, Eric; Fuchs, James; Kinghorn, Alan "Dr. A. Douglas Kinghorn"; Parinandi, Narasimham
- Licensing Officer: Willson, Christopher
Topical Compounds to Treat Leishmania
TS-014819 — A new class of drugs for the treatment of Leishmania.
Leishmaniasis is an infection caused by Leishmania parasites, spread by the bite of phlebotomine sand flies. It is prevalent in the tropics, subtropics, and southern Europe and is considered a neglected disease. Over a million people are infected with the parasite yearly, leading to skin sores and i…
- College: College of Medicine (COM)
- Inventors: Satoskar, Abhay; Fuchs, James; Isaac-Marquez, Angelica; Kinghorn, Alan "Dr. A. Douglas Kinghorn"; Lezama-Davila, Claudio; Pan, Li
- Licensing Officer: Schultz, Teri
